Twareat Medical Care Company (TADAWUL:9627)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
12.00
+0.02 (0.17%)
Apr 14, 2026, 10:58 AM AST

TADAWUL:9627 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
183.1191.81154.72149.51
Revenue Growth (YoY)
-4.54%23.97%3.49%-
Cost of Revenue
140.16131.69107.0890.93
Gross Profit
42.9560.1247.6558.57
Selling, General & Admin
35.5933.9728.5325.18
Amortization of Goodwill & Intangibles
--0.150.09
Operating Expenses
50.43531.8431.7
Operating Income
-7.4525.1215.8126.87
Interest Expense
-2.26-0.64-0.53-0.65
Other Non Operating Income (Expenses)
-0.030.420.230.64
EBT Excluding Unusual Items
-9.7324.915.5226.87
Gain (Loss) on Sale of Assets
---0.09
Pretax Income
-9.7324.915.5226.96
Income Tax Expense
0.591.391.351.52
Net Income
-10.3223.5114.1725.43
Net Income to Common
-10.3223.5114.1725.43
Net Income Growth
-65.98%-44.30%-
Shares Outstanding (Basic)
404040-
Shares Outstanding (Diluted)
404040-
EPS (Basic)
-0.260.590.35-
EPS (Diluted)
-0.260.590.35-
EPS Growth
-65.98%--
Free Cash Flow
-6.542.541.4818.54
Free Cash Flow Per Share
-0.160.060.04-
Dividend Per Share
-0.2500.2401.600
Dividend Growth
-4.17%-85.00%-
Gross Margin
23.46%31.34%30.80%39.18%
Operating Margin
-4.07%13.10%10.22%17.97%
Profit Margin
-5.64%12.26%9.16%17.01%
Free Cash Flow Margin
-3.57%1.32%0.95%12.40%
EBITDA
-2.9428.4218.1328.23
EBITDA Margin
-1.60%14.81%11.72%18.88%
D&A For EBITDA
4.513.32.321.36
EBIT
-7.4525.1215.8126.87
EBIT Margin
-4.07%13.10%10.22%17.97%
Effective Tax Rate
-5.57%8.69%5.65%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.